Celgene (CELG) Tops Q2 EPS by 5c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Celgene Reports Second Quarter 2018 Operating and Financial Results
July 26, 2018 7:30 AM EDTStrong total net product sales of $3.8 billion, increased 17% Y/Y
Raising full-year total revenue guidance to ~$15 billion and REVLIMID® net sales to ~$9.7 billion
Advancing late-stage next-generation growth drivers
SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) reported net product sales of $3,808 million for the second quarter of 2018, a 17 percent increase from the same period in 2017. Celgene reported second quarter 2018 total revenue of $3,814 million, a 17 percent increase compared to $3,271 million in the second quarter of 2017.
Based on U.S. GAAP... More
